Join Dr. Rick Baehner, Chief Medical Officer of the Precision Oncology division at Exact Sciences, in this episode of Becker's Healthcare Podcast. Dr. Baehner discusses the evolving landscape of precision oncology and how Exact Sciences is equipped to address the dynamic challenges and opportunities in molecular testing for cancer patients. He shares key milestones that highlight the company's commitment to innovation. Exploring the role of technology in cancer prevention, early detection, and improved treatment guidance, Dr. Baehner explains how Exact Sciences aligns with these objectives while addressing the concerns of cancer leaders. Discover what exciting goals and developments are on the horizon for Exact Sciences and tune in for Dr. Baehner's closing thoughts on this insightful journey.
This episode is sponsored by Exact Sciences.
Cologuard is intended to screen adults 45 and older at average risk for colorectal cancer. Rx only. Please see Cologuard Indications and Important Risk Information at Cologuardhcp.com/risk-information. Exact Sciences' MCED and MRD tests are under development. The features discussed in this podcast describe current development goals. It has not been cleared or approved by the US Food and Drug Administration or any other national regulatory authority.
